Solid Biosciences (SLDB) Cash from Investing Activities Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -674.01% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -166.24% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -122.45% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 262.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 262.98% |
| Dec 31, 2025 | 21.90% |
| Sep 30, 2025 | -312.06% |
| Jun 30, 2025 | -532.38% |
| Mar 31, 2025 | 28.65% |
| Dec 31, 2024 | -14.86% |
| Sep 30, 2024 | 55.40% |
| Jun 30, 2024 | 89.27% |
| Mar 31, 2024 | -203.30% |
| Dec 31, 2023 | -31.47% |
| Sep 30, 2023 | -265.24% |
| Jun 30, 2023 | 19.07% |
| Mar 31, 2023 | -1.28% |
| Dec 31, 2022 | 119.05% |
| Sep 30, 2022 | 120.56% |
| Jun 30, 2022 | -22.33% |
| Mar 31, 2022 | 107,937.14% |
| Dec 31, 2021 | 50,393.33% |
| Sep 30, 2021 | -90,537.50% |
| Jun 30, 2021 | -15,229.50% |
| Mar 31, 2021 | -100.55% |
| Dec 31, 2020 | -102.10% |
| Sep 30, 2020 | -102.02% |
| Jun 30, 2020 | -98.67% |
| Mar 31, 2020 | 199.58% |
| Dec 31, 2019 | 113.43% |
| Sep 30, 2019 | 383.68% |
| Jun 30, 2019 | 1,069.60% |
| Mar 31, 2019 | -300.06% |
| Dec 31, 2018 | -657.00% |
| Sep 30, 2018 | 80.90% |
| Jun 30, 2018 | -118.29% |
| Mar 31, 2018 | -123.14% |